Chicagoest - I finally found where the NNT was 30, well it was actually an NNT of 31

BDAZ posted the abstract for the presentation at ESC 2020 on Aug 26 at 11:52am

Looks like Dr. Kausik Ray will give a presentation on Friday August 28th for ESC 2020. Abstract copied below. The table and graph can be viewed in the link. 

Apabetalone, a selective BET protein inhibitor, reduces ischemic cardiovascular events and hospitalization for heart failure in patients with acute coronary syndrome and type 2 diabetes

In the RESULTS section there it was "At 26 months, the absolute risk reduction was 3.2% and number needed to treat was 31. Numerically favorable HRs were observed for each component endpoint except for stroke (Table)."

tada